2018
DOI: 10.1159/000496544
|View full text |Cite
|
Sign up to set email alerts
|

Plasma C-Type Natriuretic Peptide: Emerging Applications in Disorders of Skeletal Growth

Abstract: Although studies in experimental animals show that blood levels of C-type natriuretic peptide (CNP) and its bioinactive aminoterminal propeptide (NTproCNP) are potential biomarkers of long bone growth, a lack of suitable assays and appropriate reference ranges has limited the application of CNP measurements in clinical practice. Plasma concentrations of the processed product of proCNP, NTproCNP – and to a lesser extent CNP itself – correlate with concurrent height velocity throughout all phases of normal skele… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
13
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 15 publications
(13 citation statements)
references
References 72 publications
0
13
0
Order By: Relevance
“…In younger rats whose growth plates are thicker, Nppc expression in growth plates would have more impact on the circulating NT-proCNP. Actually in humans, NT-proCNP levels in children are about 2-3 times higher than those in adults [58,59]. Thus our experiments using 4-week-old rats are likely to emphasize the effect of local Nppc change on circulating NT-proCNP.…”
Section: Discussionmentioning
confidence: 79%
“…In younger rats whose growth plates are thicker, Nppc expression in growth plates would have more impact on the circulating NT-proCNP. Actually in humans, NT-proCNP levels in children are about 2-3 times higher than those in adults [58,59]. Thus our experiments using 4-week-old rats are likely to emphasize the effect of local Nppc change on circulating NT-proCNP.…”
Section: Discussionmentioning
confidence: 79%
“…Although we analysed associations in each sex separately, and have eliminated the influence of age (which reduces androgens in both males and females), effects of androgens on relationships of ANP/BNP with risk cannot be excluded but are likely to be small. The possibility that the positive links of NTproCNP with impaired cardiac and metabolic health reflect resistance to the peptide’s actions in tissues 4 – rather than an adaptive response to vascular stress – cannot be excluded. Finally although participants were free of heart disease and were asymptomatic, increase in BNP in some may be due to subtle increases in LV hypertrophy and or end diastolic pressure.…”
Section: Discussionmentioning
confidence: 99%
“…Compared to ANP and BNP, much less is known concerning C-type Natriuretic Peptide (CNP). CNP, acting via its receptor NPR2, is a paracrine/autocrine growth factor which drives postnatal endochondral bone growth 3,4 , has recognised anti-inflammatory and anti-proliferative actions in the vascular intima 5 , and is thought to have important roles in regulating pressure and flow in the microcirculation 6 . CNP is also expressed in myocardial tissues though its contribution to cardiac performance in humans remains unclear 7 .…”
Section: Introductionmentioning
confidence: 99%
“…Importantly, CNP pathway is one of the possible targets for new treatments in more common dysplasias like achondroplasia. CNP pathway modulation has been used in several experimental studies and clinical trials (Lorget et al, 2012, Espiner et al, 2018, Yotsumoto et al, 2019.…”
Section: Discussionmentioning
confidence: 99%